Articles

Normal karyotype is a poor prognostic factor in myeloid leukemia of Down syndrome: a retrospective, international study

Pediatric Oncology- Hematology, Erasmus MC– Sophia Children’s Hospital, Rotterdam, the Netherlands
Acute Myeloid Leukemia Berlin-Frankfurt-Munster Study Group, Department of Pediatric Oncology/Hematology, Medical School, Hannover, Germany
Acute Myeloid Leukemia Berlin-Frankfurt-Munster Study Group, Department of Pediatric Oncology/Hematology, Medical School, Hannover, Germany
Acute Myeloid Leukemia Berlin-Frankfurt-Munster Study Group, Department of Pediatric Oncology/Hematology, Medical School, Hannover, Germany
Dutch Childhood Oncology Group, The Hague, the Netherlands
Nordic Society for Pediatric Hematology and Oncology, Department of Pediatrics, Aarhus University Hospital Skejby, Aarhus, Denmark
Division of Hematology/Oncology, Cincinnati Children’s Hospital Medical Center, OH, USA
Hematologic Malignancies Unit, The Center for Pediatric Hematology Oncology, Schneider Children’s Medical Center, Petach Tikvah, Israel
Pediatric Oncology and Hematology, Children’s Hospital, Bordeaux, France
Pediatric Oncology and Hematology, University of Bologna, Italy
Department of Pediatrics, University Hospital, Hradec Kralové, Czech Republic
Hong Kong Pediatric Hematology Oncology Study Group, Department of Pediatrics and Adolescent Medicine, The University of Hong Kong, Hong Kong, China
Division of Hematology and Oncology, Shizuoka Children’s Hospital, Japan
Department of Pediatrics, Shiga University of Medical Science, Japan
Leukemia/Lymphoma Division, St. Jude Children’s Research Hospital, Memphis, TN, USA
Departments of Pediatrics, Semmelweis University of Medicine, Budapest, Hungary
Department of Pediatric Oncology and Hematology, Polish-American Institute of Pediatrics, Jagiellonian University Medical College, Krakow, Poland
Pediatric Oncology- Hematology, Erasmus MC– Sophia Children’s Hospital, Rotterdam, the Netherlands;Dutch Childhood Oncology Group, The Hague, the Netherlands
Department of Medical Bioscience, Genetics, University of Umeå, Sweden
Department of Clinical Genetics, University and Regional Laboratories, Skåne University Hospital, Lund University, Lund, Sweden
Pediatric Oncology- Hematology, Erasmus MC– Sophia Children’s Hospital, Rotterdam, the Netherlands;Dutch Childhood Oncology Group, The Hague, the Netherlands
Pediatric Oncology- Hematology, Erasmus MC– Sophia Children’s Hospital, Rotterdam, the Netherlands;Dutch Childhood Oncology Group, The Hague, the Netherlands
Vol. 99 No. 2 (2014): February, 2014 https://doi.org/10.3324/haematol.2013.089425